Drug Database
IN

insulin (Rinsulin R)

✓ Approved

GeroPharm · INSR · 重组蛋白

什么是 insulin?

insulin 是一种重组蛋白,由GeroPharm研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection、Intravenous (IV)、Subcutaneous Injection。

药物档案

商品名Rinsulin R
公司GeroPharm
药物类别重组蛋白
分子靶点INSR
给药途径Injectable (Others), Intramuscular (IM) Injection, Intravenous (IV), Subcutaneous Injection
状态Approved

作用机制

分子靶点

insulin 作用于 1 个分子靶点:

INSRinsulin receptor (CD220, HHF5)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

insulin 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Metabolism and nutrition disordersType 1 diabetes mellitus✓ Approved
Metabolism and nutrition disordersType 2 diabetes mellitus✓ Approved

相关研究文献

PubMedDiabetes, obesity & metabolism2026-11-19

Insulin Secretion Modelling to Characterize Post-Bariatric Hypoglycaemia After Roux-en-Y Gastric Bypass.

Mohammadi-Asl E E, El Fathi A A, Pei L L, Saeed H H et al.

Roux-en-Y Gastric Bypass (RYGB) is an effective treatment for obesity and Type 2 diabetes. Some individuals develop postprandial hypoglycaemia, termed post-bariatric hypoglycaemia (PBH). PBH is associated with marked postprandial increases in incretin and insulin levels. This study investigates how insulin secretion differs between post-RYGB patients with and without hypoglycaemia by identifying key secretion parameters. Insulin secretion was modelled using plasma glucose, insulin and C-peptide concentration data obtained from mixed meal tolerance test in three cohorts: healthy individuals without a history of upper gastrointestinal surgery (controls, n = 11), post-RYGB individuals without hypoglycaemia (RYGB-non-hypo, n = 18) and post-RYGB individuals with hypoglycaemia (RYGB-PBH, n = 20). Meal-driven insulin secretion differed across groups (p = 0.008) and was significantly higher in RYGB-PBH than controls (0.23 vs. 0.14 pmol/mg, p = 0.006), but not in RYGB-non-hypo (0.22, p = 0.071). Glucose-driven insulin secretion decreased in RYGB-non-hypo (0.04 vs. 0.07 pmol/kg/min per mg/dL, p = 0.005) but did not differ from controls in RYGB-PBH (0.08, p = 0.948), differing significantly between the two post-RYGB groups (p < 0.001). Meal absorption was significantly faster in both post-RYGB groups (9.08 and 8.44 vs. 11.48 min, both p < 0.001). Models fit plasma insulin and C-peptide well (mean joint nRMSE: 0.60-0.92 across groups). Parameters were estimated with good precision (CV < 100%). Insulin secretion dynamics differ between post-RYGB patients with and without hypoglycaemia. Both groups showed faster meal absorption and a shift towards higher meal-driven secretion, significant only in RYGB-PBH, but only those without hypoglycaemia showed a reduction in glucose-driven secretion. This PBH model can support in silico development of glucagon-based interventions.

PMID 43053530
阅读全文 →
PubMedEndocrinology, diabetes & metabolism2026-11-19

Prevalence of Self-Reported Hypoglycemia and Associated Factors Among Patients With Type 1 Diabetes Mellitus Attending Follow-Up Care at Bule Hora University Teaching Hospital, Southern Ethiopia.

Gerina Aliyi A, Bati Lencho L, Elema Woyesa W, Jatani Gelgelo Gerbicha GG

Hypoglycemia is the most common acute complication of insulin therapy among individuals with Type 1 diabetes mellitus (T1DM) and remains a major barrier to achieving optimal glycemic control. Recurrent hypoglycemia is associated with increased morbidity, impaired quality of life, poor treatment adherence, and increased healthcare utilization. Despite the growing burden of T1DM in Ethiopia, evidence regarding the prevalence of hypoglycemia and its associated factors remains limited, particularly in resource-constrained settings. This study aimed to determine the prevalence of self-reported hypoglycemia and its associated factors among patients with Type 1 diabetes mellitus attending follow-up care at Bule Hora University Teaching Hospital, Southern Ethiopia. A hospital-based cross-sectional study was conducted among 198 T1DM patients attending follow-up care at BHUTH from January 1 to march 31, 2025. A census sampling technique was employed to include all eligible participants. Data were collected using a structured interviewer-administered questionnaire and medical record review. Descriptive statistics were used to summarize participant characteristics. Bivariable and multivariable logistic regression models and statistical significance were declared at p < 0.05. A total of 198 participants were included in the study. The prevalence of self-reported hypoglycemia was 42.0% (95% CI: 35.5%-49.3%). Participants living ≥ 5 km from the health facility had significantly higher odds of experiencing hypoglycemia than those living within 5 km (AOR = 3.15; 95% CI: 1.58-6.31; p = 0.001). Conversely, participants who practiced self-monitoring of blood glucose had significantly lower odds of hypoglycemia than those who did not (AOR = 0.12; 95% CI: 0.06-0.26; p < 0.001). Nearly half of the study participants experienced at least one episode of hypoglycemia. Regular self-monitoring of blood glucose was associated with a lower risk of hypoglycemia, whereas greater distance from the healthcare facility increased the risk.

PMID 43053656
阅读全文 →
PubMedWorld journal of psychiatry2026-11-19

Correction to: KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer's disease.

Lu Qun-Shan QS, Ma Lin L, Jiang Wen-Jing WJ, Wang Xing-Bang XB et al.

[This corrects the article DOI: 10.5498/wjp.v14.i3.445.][This corrects the article on p. 445 in vol. 14, PMID: 38617985.].

PMID 43053753
阅读全文 →
PubMedAJE advances : research in epidemiology2026-11-19

Patient-physician language concordance and long-term mortality: a retrospective cohort study of Canadians.

Reaume Michael M, Holahan Benjamin B, Labossière Mathieu N MN, Kilabuk Elaine E et al.

Linguistic diversity across North America is increasing rapidly. Prior studies have shown that patients who receive healthcare services in their preferred language have better short-term outcomes. We sought to determine whether patient-physician language concordance is associated with all-cause death in Canada. We performed a population-based, retrospective cohort study using data from the Canadian Community Health Survey from January 1, 2003 to December 31, 2014 linked to mortality records (until December 31, 2017). We determined respondents' primary home language using language spoken most often at home (English, French, Indigenous language, or Allophone language [ie, other language]). We defined patient-physician language concordance as agreement between respondents' primary home language and the language spoken with their regular medical doctor. We studied a total of 50 375 respondents. Very few Indigenous-language-speaking respondents (1.8%) received regular language-concordant physician care. Patient-physician language concordance was associated with a lower risk of all-cause death among both French-speaking respondents outside of Quebec (HR 0.89, 95% CI, 0.79-1.00) and Allophone-language-speaking respondents (HR 0.73, 95% CI, 0.65-0.83). Healthcare systems should prioritize the delivery of language-concordant physician care (eg, through patient-physician linguistic matching and/or use of evidence-based interpretation services), as this could potentially improve long-term survival in linguistically diverse populations.

PMID 43053807
阅读全文 →
PubMedNature2026-11-19

A glucose-powered artificial neuroimmune axis for metabolic control.

Xiu Weijun W, Wang Qian Q, Wan Ling L, Liang Zhuoming Z et al.

Metabolic disorders such as diabetes mellitus are global health crises driven by metabolic imbalance, chronic inflammation and dysfunction of the neuroimmune axis1-3. Electroceuticals targeting the autonomic nervous system have shown anti-inflammatory effects, yet existing systems lack the metabolic interoceptive feedback to fully restore immune-metabolic homeostasis4-9. Here we report an artificial neuroimmune axis (NeuroAxis) as a closed-loop immunomodulatory therapy for treating metabolic diseases. Analogous to its biological counterpart, NeuroAxis is solely powered by endogenous glucose, operating without batteries or wireless power transfer. It emulates the vagal reflex through closed-loop neuromodulation with metabolic interoceptive feedback. In a rat model of type 1 diabetes, NeuroAxis promotes the recovery of insulin-producing pancreatic β-cells and reduces inflammatory immune responses; in a rat model of type 2 diabetes, it drives macrophage remodelling and reduces systemic chronic inflammation. In both models, NeuroAxis restores glucose tolerance, improves insulin sensitivity and normalizes glycaemic control, with therapeutic effects persisting after treatment cessation. Our artificial neuroimmune axis promotes substantial advances in treating metabolic disorders and represents a general approach for autonomously regulating interorgan communication, central to homeostasis and pathophysiology.

PMID 43052470
阅读全文 →
PubMedBMC cardiovascular disorders2026-11-19

The comparative performance of insulin resistance and visceral adiposity composites over traditional indices for cardiometabolic multimorbidity risk stratification: a multi-dimensional analysis of 16 markers and 5 pathophysiological pathways in the CHARLS cohort.

Zhang Lisha L, Zhang Yan Y, Deng Fuxue F, Jiang Wei W et al.

To compare the associations and incremental discriminatory ability of 16 alternative metabolic markers with incident cardiometabolic multimorbidity (CMM) and explore potential mediating pathways. Using the CHARLS cohort (n = 7,646), we evaluated 16 markers. Primary analyses comprised Cox regression, competing-risk models, and ROC/IDI/NRI assessments of incremental discrimination. XGBoost, qgcomp, and SEM served as secondary/exploratory analyses of feature importance, mixture effects, and mediation pathways. During follow-up, 633 participants developed CMM. All markers were significantly associated with CMM in quartile analyses; CVAI showed the strongest association (Q4 vs. Q1 HR: 5.15, 95% CI: 3.52-7.54). TyG-WC provided the greatest incremental improvement in discrimination (IDI = 0.026, NRI = 0.255, P < 0.001). Composite insulin resistance (IR) and atherogenic lipid indices accounted for 87.8% of the joint risk weight. SEM revealed a suppression pattern: biochemical IR statistically accounted for the association between structural (anthropometric) adiposity and CMM (indirect effect: 0.34, P < 0.001; mediation proportion: 121.9%, reflecting inconsistent mediation rather than complete mediation), while the direct effect of structural adiposity was negative and non-significant (P > 0.05). Integrating biochemical and anthropometric markers (particularly TyG-WC) improves CMM risk stratification, although the incremental gains were modest and require external validation before clinical implementation. The association between structural adiposity and CMM was statistically accounted for by biochemical IR; in exploratory SEM analyses, structural obesity without metabolic dysfunction was not independently associated with CMM in this cohort. Whether this reflects a metabolically healthy phenotype warrants further study. Not applicable.

PMID 43052776
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多insulin